[Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
D000368:Aged; D001545:Benserazide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005556:Form Perception / Q000187:drug effects; D006801:Humans; D007361:Intelligence Tests; D007980:Levodopa / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D010468:Perceptual Disorders / Q000209:etiology; D011340:Problem Solving / Q000187:drug effects; D013028:Space Perception / Q000187:drug effects*; D013850:Thinking / Q000187:drug effects*; D014796:Visual Perception / Q000187:drug effects*; D014888:Wechsler Scales
D007980:Levodopa; D001545:Benserazide
Die Beeinflussung visuell-räumlicher Leistungsstörungen von Parkinson-Kranken durch die L-Dopa-Behandlung